-+ 0.00%
-+ 0.00%
-+ 0.00%

N2OFF COMPLETED MERGER WITH CANCER DRUG DISCOVERY COMPANY TARGETING TOUGH-TO-TREAT PANCREATIC AND LUNG CANCERS

Reuters·10/30/2025 13:25:00

Please log in to view news